Stuart J Connolly, MD

All posts by Stuart J Connolly, MD

November 4th, 2013

Should Plasma Levels of Dabigatran Guide How We Dose the Drug?

Stuart J. Connolly discusses his research group’s analysis of data from the RE-LY trial, concerning the relationship between plasma concentrations of dabigatran and the risks for ischemic events and major bleeding.